Nov 26, 2022

CRISPR vs breast, colon, lung cancer: First human trial goes well

Posted by in categories: bioengineering, biotech/medical

A small human trial has tested CRISPR gene editing technology in the treatment of solid cancer tumors, including breast, colon, and lung cancer, with promising results.

Comments are closed.